Session Details

Anxiety and Pain

Tuesday, 10 February 2004 14:30 -16:15

Promenade Meeting Room 6

Co-Chair Michael J Detke Eli Lilly and Company; Indiana University Medical SchoolUnited States
Co-Chair Dr Philip LP Morris University QueenslandAustralia

Efficacy of duloxetine in the treatment of the pain associated with diabetic neuropathy
  • Michael J Detke, Eli Lilly and Company; Indiana University School of Medicine, United States
  • A double-blind, multicenter trial comparing Duloxetine to placebo in the treatment of fibromyalgia with or without major depressive disorder
  • Michael J Detke, Eli Lilly and Company; Indiana University Medical School, United States
  • Significant level of anxiety on colombian children: Effect of chronic community violence?
  • Dr Ruby C Castilla, Worldwide Epidemiology GlaxoSmithKline, University of North Carolina, United States
  • Benzodiazepine receptor characteristics distinguish PTSD from panic disorder
  • Dr Philip LP Morris, University Queensland, Australia
  • Megestrol attenuates hormonal response to CCK-4
  • Thomas J Raedler, University Hospital Hamburg-Eppendorf, Germany
  • Is combination of psychopharmacotherapy and psychotherapy effective at treatment of agoraphobia with a panic disorder?
  • Milan Ignjatovic, Non Governmental Psychiatric Health Clinic, Slovak Republic